Related Experiment Videos
LMX1B transactivation and expression in nail-patella syndrome
S D Dreyer1, R Morello, M S German
1Children's Hospital, University of Mainz, Langenbeckstr. 1, D-55101 Mainz, Germany.
Human Molecular Genetics
|April 18, 2000
Summary
Mutations in LMX1B cause nail-patella syndrome (NPS) by affecting dorsal limb development. This study reveals LMX1B
Area of Science:
- Developmental Biology
- Molecular Genetics
- Skeletal Dysplasias
Background:
- Lmx1b is a LIM homeodomain protein crucial for vertebrate dorsal limb development.
- Nail-patella syndrome (NPS) is a skeletal dysplasia linked to mutations in LMX1B.
- The transcriptional mechanisms and spatial gene expression patterns underlying NPS remain unclear.
Purpose of the Study:
- To investigate the transcriptional mechanisms and spatial gene expression of Lmx1b in limb development.
- To elucidate how LMX1B mutations lead to the NPS phenotype.
- To determine the mechanism of NPS pathogenesis at the molecular level.
Main Methods:
- In situ hybridization of Lmx1b in murine limb sections.
- Transfection studies with LMX1B, LDB1, and E47/shPan1.
- Reporter activity assays and mixing studies with mutant LMX1B proteins.
Main Results:
- Lmx1b is expressed in dorsal mesenchymal tissues and anterior limb structures, correlating with NPS dysplasia patterns.
- LDB1 down-regulates LMX1B activity, while E47/shPan1 synergizes with LMX1B.
- Mutations in LMX1B's homeodomain abolish transactivation, while LIM B/truncation mutations retain partial activity.
- Mutant LMX1B proteins do not act in a dominant-negative manner on wild-type LMX1B.
Conclusions:
- LMX1B's spatial expression pattern explains the gradient of dysplasia in NPS.
- LMX1B activity is modulated by LDB1 and E47/shPan1.
- Haploinsufficiency, not dominant-negative effects, underlies NPS pathogenesis due to LMX1B mutations.